Purchase Order 75N91019P00561

The National Cancer Institute issued a purchase order to Coherent Inc. on June 30, 2021, valued at $14,751.77, for maintenance agreement services with an ultimate completion date of July 24, 2022. The order represents a firm fixed-price acquisition to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of fund availability. Performance occurs in Bethesda, Maryland. No small business...

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $8,800.00 on January 18, 2018, with completion scheduled for February 11, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $7,072.75 on July 2, 2018, with an ultimate completion date of August 2, 2018. The order is a firm fixed-price acquisition with no set-aside designation. Place of performance is Bethesda, Maryland. The procurement is for coherent laser group equipment and services [18-046094], typical of the vendor's federal portfolio of precision laser systems and related instrumentation for scientific research applications.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. on December 18, 2017, with a ceiling value of $5,566.05 and an ultimate completion date of December 28, 2018. The order is firm fixed price with no set-aside. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $19,190 on July 25, 2018, for a maintenance agreement on a Coherent laser group system. Performance is located in Santa Clara, California, with an ultimate completion date of July 24, 2019. The order is firm fixed-price; no set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $133,380.00 on September 28, 2017, with an ultimate completion date of November 16, 2017. The order is firm fixed-price with no small business set-aside. Performance takes place in Santa Clara, California. The source does not specify the laser systems or equipment being purchased.</p>

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $21,636 firm fixed price purchase order to Coherent NA, Inc. for a service agreement covering the Chameleon Vision II and Chameleon MPX X laser system. Coherent NA, Inc. is a subsidiary of Coherent Inc. and will perform the work at its Rockville, Maryland facility located at 20852. The period of performance is one year, running from July 25, 2023 through July 24, 2024. No additional...

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $20,283.34 on April 24, 2020, for a service agreement with a firm fixed price. Work is performed in Bethesda, Maryland. The order is set to complete by July 19, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $16,085.00 on May 17, 2019, with ultimate completion on June 14, 2020. Performance occurs in Bethesda, Maryland. The order is a firm fixed price service agreement with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>